Wim H. Scheele

1.3k total citations
13 papers, 905 citations indexed

About

Wim H. Scheele is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Wim H. Scheele has authored 13 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in Wim H. Scheele's work include Bone health and treatments (5 papers), Bone health and osteoporosis research (5 papers) and Estrogen and related hormone effects (4 papers). Wim H. Scheele is often cited by papers focused on Bone health and treatments (5 papers), Bone health and osteoporosis research (5 papers) and Estrogen and related hormone effects (4 papers). Wim H. Scheele collaborates with scholars based in United States, Canada and Mexico. Wim H. Scheele's co-authors include Jean‐Yves Reginster, Olof Johnell, Allan G. Need, Ego Seeman, Yili Lu, Paul D. Miller, Robin K. Dore, Αλεξάνδρα Παπαϊωάννου, Anne Peretz and Anthony B. Hodsman and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Joint Surgery and Journal of the American Society of Nephrology.

In The Last Decade

Wim H. Scheele

12 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wim H. Scheele United States 8 642 524 382 141 128 13 905
Adrien Sipos United States 9 703 1.1× 626 1.2× 443 1.2× 49 0.3× 108 0.8× 11 920
S. Paul United States 8 459 0.7× 476 0.9× 255 0.7× 49 0.3× 95 0.7× 14 707
S. Horlait France 11 542 0.8× 368 0.7× 311 0.8× 56 0.4× 183 1.4× 13 751
Douglas W. Axelrod United States 7 498 0.8× 465 0.9× 319 0.8× 47 0.3× 68 0.5× 13 847
F. J. F. E. Vismans Netherlands 8 448 0.7× 459 0.9× 309 0.8× 52 0.4× 62 0.5× 11 709
PD Delmas France 5 438 0.7× 355 0.7× 211 0.6× 43 0.3× 75 0.6× 11 712
Moo-Il Kang South Korea 18 224 0.3× 197 0.4× 328 0.9× 71 0.5× 203 1.6× 57 911
Kiyoshi Nakatsuka Japan 16 401 0.6× 556 1.1× 314 0.8× 171 1.2× 140 1.1× 41 1.1k
Leonardo Bandeira Brazil 14 310 0.5× 332 0.6× 198 0.5× 104 0.7× 273 2.1× 23 925
Pietra Pennisi Italy 10 267 0.4× 150 0.3× 203 0.5× 52 0.4× 100 0.8× 13 594

Countries citing papers authored by Wim H. Scheele

Since Specialization
Citations

This map shows the geographic impact of Wim H. Scheele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim H. Scheele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim H. Scheele more than expected).

Fields of papers citing papers by Wim H. Scheele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim H. Scheele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim H. Scheele. The network helps show where Wim H. Scheele may publish in the future.

Co-authorship network of co-authors of Wim H. Scheele

This figure shows the co-authorship network connecting the top 25 collaborators of Wim H. Scheele. A scholar is included among the top collaborators of Wim H. Scheele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim H. Scheele. Wim H. Scheele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gale, Jeremy D., Steven A. Gilbert, Samuel S. Blumenthal, et al.. (2018). Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy. Kidney International Reports. 3(6). 1316–1327. 38 indexed citations
2.
Scheele, Wim H., Susan M. Diamond, Jeremy D. Gale, et al.. (2016). Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy. Journal of the American Society of Nephrology. 27(11). 3459–3468. 53 indexed citations
3.
Lyon, Thomas R., Wim H. Scheele, Mohit Bhandari, et al.. (2013). Efficacy and Safety of Recombinant Human Bone Morphogenetic Protein-2/Calcium Phosphate Matrix for Closed Tibial Diaphyseal Fracture. Journal of Bone and Joint Surgery. 95(23). 2088–2096. 46 indexed citations
4.
Lindsay, Robert, Wim H. Scheele, Robert M. Neer, et al.. (2004). Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis. Archives of Internal Medicine. 164(18). 2024–2024. 237 indexed citations
5.
Johnell, Olof, Wim H. Scheele, Yili Lu, et al.. (2002). Additive Effects of Raloxifene and Alendronate on Bone Density and Biochemical Markers of Bone Remodeling in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 87(3). 985–992. 169 indexed citations
6.
Body, Jean‐Jacques, Gregory Gaich, Wim H. Scheele, et al.. (2002). A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 87(10). 4528–4535. 277 indexed citations
7.
Fugère, P, Wim H. Scheele, Aarti S. Shah, et al.. (2000). Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women. American Journal of Obstetrics and Gynecology. 182(3). 568–574. 39 indexed citations
8.
Goldstein, Steven R., et al.. (2000). A 12-Month Comparative Study of Raloxifene, Estrogen, and Placebo on the Postmenopausal Endometrium. Obstetrics and Gynecology. 95(1). 95–103. 5 indexed citations
9.
Lord, Stephen R., Yifei Lü, Mark Lakshmanan, M. Wong, & Wim H. Scheele. (1999). Raloxifene Does Not Affect Neuromuscular Function or the Incidence of Falls in Postmenopausal Women with Osteoporosis. Menopause The Journal of The North American Menopause Society. 6(4). 347–348. 1 indexed citations
10.
Shah, Aarti S., Wim H. Scheele, Michael D. Glant, & P Fugère. (1998). Raloxifene HCl is not stimulatory in the endometrium as assessed by the blaustein criteria and an estrogenicity scoring system. Primary Care Update for OB/GYNS. 5(4). 167–167. 4 indexed citations
11.
Scheele, Wim H., et al.. (1997). The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: Results of three years of treatment. Osteoporosis International. 7(1). 52–58. 29 indexed citations
12.
Goldstein, Steven R., et al.. (1997). S-12.. Menopause The Journal of The North American Menopause Society. 4(4). 250–250. 6 indexed citations
13.
Scheele, Wim H., et al.. (1993). The use of etidronate and calcium vs calcium in the treatment of postmenopausal osteopenia First report of interim results. 1. 74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026